大博医疗：全资子公司收购关联方部分股权

Group 1 - The core point of the article is that Dabo Medical announced a plan to acquire a 45.08% stake in Baimaisi (Xiamen) Medical Technology Co., Ltd. from its shareholder He Xizhong for a consideration of 3.7645 million RMB to standardize and reduce related party transactions and leverage Baimaisi's sales advantages to increase market share for its subsidiary [1] Group 2 - Dabo Medical's subsidiary, Shenzhen World Surgical Medical Device Technology Co., Ltd., aims to enhance its product market share through this acquisition [1] - The acquisition is part of a strategy to optimize the company's operations and improve its competitive position in the medical device sector [1]